2018 updated European League Against Rheumatism evidence-based recommendations for the diagnosis of gout
Annals of the Rheumatic Diseases2019Vol. 79(1), pp. 31–38
Citations Over TimeTop 1% of 2019 papers
Pascal Richette, Michael Doherty, Eliseo Pascual, В Г Барскова, Fabio Becce, Johann Castaneda, M. Coyfish, S. Guillo, Tim Jansen, Hein Janssens, Frédéric Lioté, Christian Mallen, George Nuki, Fernando Pérez-Ruiz, José Bravo Pimentão, Leonardo Punzi, Anthony Pywell, Alexander So, Anne‐Kathrin Tausche, Till Uhlig, Jakub Závada, Weiya Zhang, Florence Tubach, Thomas Bardin
Related Papers
- → Febuxostat in the treatment of gout: 5-yr findings of the FOCUS efficacy and safety study(2008)249 cited
- → Efficacy and safety during extended treatment of lesinurad in combination with febuxostat in patients with tophaceous gout: CRYSTAL extension study(2019)24 cited
- → SAT0329 Lesinurad, A Novel Selective Uric Acid Reabsorption Inhibitor, in Combination with Febuxostat, in Patients with Tophaceous Gout: the Crystal Phase III Clinical Trial(2015)16 cited
- → Lesinurad in hyperuricaemia of gout: a profile of its use in the EU(2018)1 cited
- → REDUCTION IN GOUT FLARES AND TOPHUS SIZE IN THE 52-WEEK FEBUXOSTAT ALLOPURINOL CONTROLLED TRIAL (FACT)(2006)